Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Revance Therapeutics Inc (RVNC)
Revance Therapeutics Inc (RVNC) Financials

RVNC Revance Therapeutics Inc

3.05

-0.03 (-0.97%)

20 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-37.182	-48.229	-54.619	-56.272	-53.199	-44.96	-64.043	-61.109
Return on Equity (%)	-41.49	-54.085	-68.796	-85.92	-94.064	-127.071	-879.284	466.153
Return on Invested Capital (%)	-36.451	-52.752	-71.169	-90.18	-68.415	-58.886	-71.466	-76.956
Operating Margin (%)	-29396	-45851.145	-3741.593	-38602.663	-1758.962	-353.527	-255.911	-130.033
Net Profit Margin (%)	-29756.667	-46025.573	-3823.223	-38602.663	-1840.711	-361.59	-268.866	-138.432
Book Value Per Share	6.26	7.362	3.938	4.305	2.255	-1.87	-1.112	-1.838
Earnings Per Share	-3.156	-3.302	-3.856	-3.044	-4.078	-3.93	-4.326	-3.689
Cash Per Share	2.245	7.747	1.981	3.255	4.822	1.545	1.323	1.564
Working Capital Per Share	6.117	7.238	4.759	4.881	5.624	2.498	3.63	2.843
Operating Profit Per Share	0.011	0.007	0.101	0.008	0.153	0.76	0.982	1.818
EBIT Per Share	-3.156	-3.302	-3.775	-3.044	-4.116	-3.93	-4.318	-3.686
EBITDA Per Share	-3.156	-3.302	-3.775	-3.044	-4.116	-3.93	-4.318	-3.686
Free Cash Flow Per Share	-3.148	-3.274	-3.713	-3.038	-4.165	-4.062	-4.697	-3.767

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	28.29M	36.52M	36.98M	52.38M	69.18M	71.58M	82.39M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	82.39M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-112.092	N/A	N/A	N/A	-85.238	N/A	N/A
Net Profit Margin (%)	N/A	-121.208	N/A	N/A	N/A	-102.341	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	323.1M
Price to Earnings Ratio	-1
Price to Sales Ratio	1.38
Price to Cash Ratio	2.35
Price to Book Ratio	-2.13
Dividend Yield	-

Share Statistics

Shares Outstanding	104.9M
Average Volume (1 week)	3.28M
Average Volume (1 Month)	3.55M
52 Week Change	-62.99%
52 Week High	9.745
52 Week Low	2.30

More Ratios Coming Soon!

Revance Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions